[Retracted] Efficacy of Dapagliflozin in Patients with Diabetes Mellitus Complicated with Coronary Artery Disease and Its Impact on the Vascular Endothelial Function

Table 4

Comparison of cardiovascular events (, %).

Cardiovascular events	Control group ()	Dapagliflozin group ()		value
Angina pectoris	8 (22.32)	3 (12.66)
Myocardial infarction	1 (3.24)	1 (3.24)
Heart failure	4 (9.98)	1 (2.13)
Cardiac death	0 (0.00)	0 (0.00)
Total incidence	13 (35.54)	5 (18.03)	4.39	0.023